Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript
Portfolio Pulse from
Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) held its Q3 2024 earnings call on November 7, 2024. Key participants included Andrea Christopher, Peter Greenleaf, Greg Keenan, and Joe Miller. Analysts from TD Cowen, Jefferies, Cantor Fitzgerald, and Leerink Partners participated.
November 07, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Aurinia Pharmaceuticals conducted its Q3 2024 earnings call, discussing financial results and company updates. The presence of analysts from major firms indicates significant interest in the company's performance.
The earnings call is a routine event where the company discusses its financial performance. The presence of analysts suggests interest, but without specific financial results or guidance, the immediate impact on stock price is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100